Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Remyelination in demyelinating disease.

N J Scolding1, R J Franklin

  • 1MRC Cambridge Centre for Brain Repair, University of Cambridge, UK.

Bailliere'S Clinical Neurology
|April 2, 1999
PubMed
Summary

Myelin repair in multiple sclerosis (MS) shows initial recovery but fails during disease progression. This chapter explores the biology of myelin repair and strategies for successful clinical translation in MS treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autologous haematopoietic stem cell transplantation for immune-mediated neurological diseases: what, how, who and why?

Practical neurology·2022
Same author

Amyloid cerebrovasculopathies.

Practical neurology·2022
Same author

Factors affecting mortality after traumatic brain injury in a resource-poor setting.

BJS open·2020
Same author

Remyelination of Demyelinated CNS Axons by Transplanted Human Schwann Cells: The Deleterious Effect of Contaminating Fibroblasts.

Cell transplantation·2017
Same author

Neurosarcoidosis: a clinical approach to diagnosis and management.

Journal of neurology·2016
Same author

Erdheim-Chester disease: 25-year history with early CNS involvement.

BMJ case reports·2016

Area of Science:

  • Neuroscience
  • Immunology
  • Regenerative Medicine

Background:

  • Multiple sclerosis (MS) involves demyelination, where myelin sheaths are damaged.
  • Partial remyelination occurs in MS lesions, aiding recovery from relapses.
  • Remyelination failure contributes to progressive disability in MS.

Purpose of the Study:

  • To explore the biological basis of myelin repair in central nervous system (CNS) demyelinating diseases.
  • To investigate reasons for failed remyelination in multiple sclerosis.
  • To discuss clinical translation of myelin repair therapies.

Main Methods:

  • Review of experimental studies on CNS myelin repair.
  • Analysis of biological mechanisms underlying remyelination.
  • Discussion of clinical trial strategies and potential challenges.

Main Results:

  • Experimental therapies demonstrate successful myelin repair in the CNS.
  • Understanding of biological factors limiting remyelination in MS.

Conclusions:

  • Therapeutic strategies for promoting myelin repair show promise for MS.
  • Clinical translation requires careful consideration of potential risks and challenges.
  • Further research is needed to overcome remyelination failure in progressive MS.

Related Experiment Videos